2 results
Categories
Human Remove Human filter
Medicine type
Generic Remove Generic filter
Additional monitoring Remove Additional monitoring filter
Biosimilar Remove Biosimilar filter
Medicine
Paediatric investigation plans Remove Paediatric investigation plans filter
Referrals Remove Referrals filter
Referral status
Procedure started Remove Procedure started filter
-
List item
Referral: Rubraca (updated)
rucaparib, associated names: Rubraca, Article 20 procedures
Status: Procedure started, Last updated: 23/05/2022 -
List item
Referral: Janus Kinase inhibitors (JAKi)
tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Procedure started, Last updated: 11/02/2022